The QualityStocks Daily Monday, May 20th, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (BIOC) +95.12%

QualityStocks (OTLK) +42.86%

TopPennyStockMovers (PXHI) +31.82%

The QualityStocks Daily Stock List

Scientific Industries, Inc. (SCND)

Zacks, Real Investment Advice, OTC Markets, Whale Wisdom, Capital Cube, Wallmine, Wallet Investor, Simply Wall St, Stockhouse, Stockopedia, Market Screener, Marketbeat, Proactive Investors, and InvestorsHub reported previously on Scientific Industries, Inc. (SCND), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Scientific Industries, Inc. designs, manufactures, and markets an array of laboratory equipment. The Company is the world leader in vortexing technologies. The Vortex-Genie Family is based upon, and originates from, the original Scientific Industries Vortex Jr. Mixer, manufactured before 1962. Scientific Industries provides benchtop laboratory equipment, customized catalyst research instruments, and bioprocessing systems and products globally. The Company is based in Bohemia, New York.

Scientific Industries is best known as the designer and manufacturer of the world-renowned Vortex-Genie® laboratory vortex mixer and shaker. This is part of a complete line of other Genie™ brand lab products. These products include microplate shakers and mixers, cell disruptor and homogenizers, magnetic stirrers, orbital shakers, rotators, rockers, and incubators.

All Genie™ products are made in the United States in its Bohemia headquarters. The Company's products are typically used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, chemical companies, and medical device manufacturers.

In 2006, Scientific Industries diversified by acquiring Altamira Instruments. Altamira is a manufacturer of custom catalyst characterization instrumentation and bench-scale micro-reactor systems for industrial and research use globally. Moreover, in 2014, Scientific Industries expanded its benchtop laboratory equipment business with the acquisition of the Torbal product line. This is a highly reputable brand with a similar long history of quality and reliability, therefore adding a laboratory scales and pharmacy pill counters product line.

Furthermore, in 2016, Scientific Bioprocessing, Inc. was relaunched. This is a subsidiary of Scientific Industries. Scientific Bioprocessing specializes in non-invasive pH and DO monitoring in cell cultivation via its patch sensor based technology acquired by Scientific Industries in 2011.

For the three and nine months ended March 31, 2019, Scientific Industries reported Net Income of $93,600 ($.06 per basic share) and $354,100 ($.24 per basic share) versus a Net Loss of $37,700 ($.03 loss per basic share) and a Net Loss of $351,500 ($.24 loss per basic share) for the three and nine months ended March 31, 2018, respectively. It reported Revenues of $3,053,500 and $7,255,300 for the three and nine months ended March 31, 2019, versus Revenues of $2,099,300 and $5,272,600, respectively, for the three and nine months ended March 31, 2018.

Scientific Industries, Inc. (SCND), closed Monday's trading session at $4.70, even for the day, on 100 volume with 1 trade. The average volume for the last 3 months is 872 and the stock's 52-week low/high is $2.96/$5.00.


Mobivity Holdings Corp. (MFON)

NetworkNewsWire, Zacks, GlobeNewswire, YCharts, Street Insider, Investors Hangout, Dividend Investor, Insider Tracking, Infront Analytics, Simply Wall St, and Equity Clock reported previously on Mobivity Holdings Corp. (MFON), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mobivity Holdings Corp. is the creator of the award-winning customer personalization platform, Recurrency. The Company provides a platform to connect national restaurants, retailers, personal care brands, and their partners, with customers to increase retention, visits, as well as spend. Mobivity Holdings lists on the OTCQB. The Company has its corporate headquarters in Chandler, Arizona and an office in Halifax, Nova Scotia.

Mobivity Holdings' Recurrency suite of products increases customer engagement and frequency through capturing detailed point-of-sale (POS) transaction records, analyzing customer habits, and motivating customers and employees via data-driven messaging applications and rewards. A business can store transactional POS data in a single location, regardless of what kind of POS system its brand uses.

The Company's patented technology is compatible with most POS systems. It installs easily to provide a simple and cost-effective data solution. The transactional data gathered via Recapture allows a business to use Recognition to gain unique insights and create more effective and flexible marketing campaigns, which drive customer frequency, through messages sent by way of Reach and printed via Receipt.

Last week, Mobivity Holdings announced financial results for Q1 ending March 31, 2019. Recurring Revenues increased to greater than $2.54 million for the quarter. This represents a 24 percent increase versus $2 million for Q1 2018. Its Net Loss increased 21 percent to $1.8 million, from $1.5 million. Adjusted EBITDA Loss (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased 31 percent from $1.8 million to $1.2 million.

The Company executed a five-year contract to power digital offer management solutions to a multi-billion-dollar brand. It also added a number of new brands to an accelerating sales pipeline totalling over $10 million in annually recurring revenue.

Furthermore, Mobivity closed partnership deals with two multi-billion-dollar Consumer Packaged Goods (CPG) brands to resell Recurrency and the newly acquired Belly loyalty platform. The Company also entered into a new partnership with a large technology investment bank to commence market trials in thousands of locations throughout Japan.

Mobivity Holdings Corp. (MFON), closed Monday's trading session at $1.06, up 1.92%, on 9,467 volume with 11 trades. The average volume for the last 3 months is 14,303 and the stock's 52-week low/high is $0.71/$1.89.


Bionik Laboratories Corp. (BNKL)

NetworkNewsWire, Zacks, MarketWatch, Real Investment Advice, Trading View, InvestorsHub, Equities, Market Screener, Marketbeat, Business Insider, Business Wire, Barchart, Last10k, 4-Traders, Stockhouse, and Wallet Investor reported previously on Bionik Laboratories Corp. (BNKL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A robotics company, Bionik Laboratories Corp. focuses on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home. Bionik has a portfolio of products centered on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients. This includes three products on the market and four products in varying stages of development. OTCQB-listed, Bionik Laboratories is based in Toronto, Ontario.

Resulting from pioneering research at the Newman Laboratory for Biomechanics and Human Rehabilitation at the Massachusetts Institute of Technology (MIT), the InMotion Robots provide effective, patient-adaptive therapy, intended to restore upper-extremity motor control for a wide range of neurological conditions and recovery stages. This includes early recovery from acute stroke.

Furthermore, InMotion Robots provide objective evaluation assessments intended to measure and report the patient's level of motor impairment and progress during the course of therapy. A home version of the InMotion upper-extremity technology is in development.

In December 2018, Bionik Laboratories announced it entered into a multi-year agreement with Kindred Hospital Rehabilitation Services for numerous units of the Company's InMotion Arm™ robotic system. With this agreement, Kindred began installing InMotion robots in its existing inpatient rehabilitation hospitals and similar facilities across the U.S. in December 2018. A second phase will include installation in new Kindred inpatient rehabilitation hospitals and similar facilities within the next four years.

This past January, Bionik Laboratories announced the commercial launch of its newest generation InMotion ARM/HAND™ robotic system for clinical rehabilitation of stroke survivors and those with mobility impairments because of neurological conditions. Bionik showcased the new technology for the first time at the American Physical Therapy Association Combined Sections Meeting (APTA CSM), which took place January 23-26, 2019 at the Walter E. Washington Convention Center in Washington, D.C.

Bionik Laboratories has completed the transition to outsourcing of the production of the newest generation InMotion ARM/HAND™ robotic system, and also the InMotion ARM™, to its manufacturing partner Cogmedix, in Massachusetts. Furthermore, the RATULS (Robot Assisted Training for the Upper Limb after Stroke) team announced that they completed study recruitment, with 770 patients participating in the trial, and results of the study are expected to be available later this year. Also, Bionik Laboratories is continuing development of a lower-limb assistive exoskeleton for individuals with impaired mobility via a previously announced manufacturing partnership with Wistron Corporation.

Bionik Laboratories Corp. (BNKL), closed Monday's trading session at $5.05, up 1.00%, on 180 volume with 3 trades. The average volume for the last 3 months is 253 and the stock's 52-week low/high is $1.00/$100.00.


FingerMotion, Inc. (FNGR)

Stock Target Advisor, Street Insider, Simply Wall St, Wallet Investor, OTC Markets, Investors Hangout, Capital Cube, Stockwatch, Stockhouse, Real Investment Advice, Trading View, and InvestorsHub reported previously on FingerMotion, Inc. (FNGR), and we also report on the Company, here at the QualityStocks Daily Newsletter.

FingerMotion, Inc. is a U.S. FinTech company with mobile payment and recharge platform operations in China. It is one of five companies in China with access to wholesale rechargeable minutes by way of top-up credits on the mobile phone. The Company's vision is to quickly grow its user base through organic means and have this growth develop into an ecosystem of users with high engagement rates using its unique applications. FingerMotion is based in China. The Company's shares trade on the OTC Markets Group's OTCQB.

The Company is developing value added technologies to market to its users. It eventually hopes to serve more than 1 billion users in the China market and eventually expand the model to other regional markets. JiuGe Information Technology is FingerMotion's wholly-owned Chinese subsidiary.

FingerMotion is investing in research and development (R&D). Its chief area of emphasis is the development of "must have" applications for consumers and businesses. The Company's longer term emphasis is to develop a marketing platform capable of taking advantage of all the meta data collected by the top telcos into a predictive model, which is able to isolate and extract consumer behavior and habits for future monetization.

In April, FingerMotion announced that its Gross Transaction Value (GTV) was $56 million in March, resulting in Gross Revenues of $280,000, up 33 percent from February's $42 million GTV and $210,000 in Gross Revenues. The Q4 ended February 28, 2019 showed GTV of $115,000. This was up 32 percent from the prior quarter.

The JiuGe Information Technology wholly-owned Chinese subsidiary has started delivering on its earlier announced SMS contracts. It expected to fulfill its contract orders for 600,000 RMB (US $88,200) in April. It expects to fulfill its contract orders for 2,000,000 RMB (US $294,000) for May, as well as 3,000,000 RMB (US $441,000) for June.

FingerMotion, Inc. (FNGR), closed Monday's trading session at $5.965, down 4.56%, on 7,557 volume with 35 trades. The average volume for the last 3 months is 5,346 and the stock's 52-week low/high is $1.98/$5.346.


Humanigen, Inc. (HGEN)

NetworkNewsWire, Street Insider, TipRanks, Insider Financial, Whale Wisdom, Equity Clock, Wallet Investor, Barchart, Stockhouse, Proactive Investors, and Investors Hub reported beforehand on Humanigen, Inc. (HGEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A biopharmaceutical company, Humanigen, Inc. is developing its portfolio of Humaneered® monoclonal antibodies centered on CAR-T optimization and immuno-oncology. In essence, the Company is developing its portfolio of Humaneered® monoclonal antibodies to address leading-edge CAR-T optimization and the need for new oncology drugs that provide safer, better, and more effective cancer therapies. OTCQB-listed and established in 2000, Humanigen is headquartered in Burlingame, California.

Humaneering is a patented proprietary technology for converting suboptimal antibodies (usually mouse) into human antibodies suitable for chronic therapies, in part, due to low immunogenicity. In completed clinical studies, the Humaneered® antibodies showed lower immunogenicity than is normally seen with competing human antibody approaches. The platform has the advantage of maintaining epitope specificity and increasing affinity.

Derived from Humanigen's Humaneered® platform, lenzilumab, ifabotuzumab and HGEN005 are monoclonal antibodies with first-in-class mechanisms. The Company's lead monoclonal antibody asset, lenzilumab, targets soluble GM-CSF. Moreover, it has been demonstrated to considerably decrease neurotoxicity and prevent cytokine release syndrome associated with CAR-T cell treatment in a proprietary human xenograft model while simultaneously increasing CAR-T cell proliferation and effector functions.

Ifabotuzumab targets the Eph type-A receptor 3 (EphA3). It is in a Phase I study as a potential treatment for glioblastoma multiforme (GBM) and being investigated for a range of solid tumors, as an optimized naked antibody and as part of an antibody-drug conjugate, and also a backbone for a novel CAR-T construct, and a bispecific antibody platform.

HGEN005 selectively targets the eosinophil receptor EMR1. It is being explored as a potential treatment for a range of eosinophilic diseases including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct.

Recently, Humanigen announced that preliminary results from a continuing Phase I bioimaging study of its proprietary anti-EphA3 monoclonal antibody, ifabotuzumab (previously known as KB004), in patients with recurrent GBM were accepted for presentation at the 2019 annual meeting of the AACR, which took place in Atlanta, Georgia, March 29 – April 3, 2019. The study demonstrates that dosing with ifabotuzumab results in rapid, specific and reproducible targeting of the tumor microenvironment without normal tissue uptake. The study suggests a direct impact of ifabotuzumab on tumor vasculature, providing evidence that targeting EphA3 expressing tumor neovasculature is a viable therapeutic strategy for solid tumors.

Last week, Humanigen announced that blood®, widely regarded as a premier journal in hematology and the official journal of the American Society of Hematology, published an article by Dr. Omar Ahmed entitled "CAR-T Cell Neurotoxicity: Hope is on the Horizon" that puts a spotlight on the unmet need to mitigate CAR-T induced NT.

The article is available online at This article expands upon the results of a study led by researchers at Harvard Medical School, Yale School of Medicine, and Massachusetts General Hospital Cancer Center entitled "Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells", which is authored by Karschnia, et al. and also featured in the current issue of 'blood'.

Humanigen, Inc. (HGEN), closed Monday's trading session at $1.27, up 15.56%, on 7,905 volume with 15 trades. The average volume for the last 3 months is 9,880 and the stock's 52-week low/high is $0.27/$1.544.


Ionix Technology, Inc. (IINX)

Small Cap Exclusive, Stockopedia, Last10k, Dividend Investor, Current Charts, Market Exclusive, Wallmine, OTC Markets, Simply Wall St, Stockhouse, Financial Content, Wallet Investor, YCharts, Barchart, The Street, Morningstar, MarketWatch, and Open Insider reported earlier on Ionix Technology, Inc. (IINX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ionix Technology, Inc. is a business aggregator in photoelectric display and smart energy fields. The Company is focusing on becoming the business aggregator that mainly promotes photoelectric display, smart energy and lead industrial technology development since restructuring. Through incorporating high quality enterprises and innovating forward-looking technologies, Ionix provides more optimized green energy solutions. The OTCQB-listed Company formerly went by the name Cambridge Projects, Inc. It changed its corporate name to Ionix Technology, Inc. in February 2016.

The Company has four operating subsidiaries. One is Changchun Fangguan Photoelectric Display Technology Co., Ltd, which specializes in developing, designing, producing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules and other related products. Another subsidiary is Shenzhen Baileqi Electronic Technology Co., Ltd, which specializes in LCD slicing, filling, researching and designing, manufacturing and selling of LCD Modules (LCM) and PCBs.

Subsidiary Dalian Shizhe New Energy Technology Co., Ltd., engages in photo-voltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three-dimensional parking. Furthermore, subsidiary Lisite Science Technology (Shenzhen) Co., Ltd., engages in the production of intelligent electronic devices. Currently, the Company has embarked on the layout of industrialization and marketization of front end materials and back end modules of flexible folding liquid crystal displays by taking Changchun Fangguan and Shenzhen Baileqi as production bases, to capture the market share of OLED high technology.

Ionix Technology announced in January 2019 that it entered into certain VIE Transaction Documents with certain shareholders of Changchun Fangguan Electronics Technology Co., Ltd. Changchun Fangguan is a leading manufacturer in the liquid crystal displays field. Through entering into specific VIE Transaction Documents, Ionix Technology acquired control of Changchun Fangguan.

Ionix Technology recently announced that its subsidiary, Changchun Fangguan Electronics Technology Co., Ltd., completed a capital increase of USD 5.92 Million to invest in its OLED flexible screen business. Ionix acquired 95.14 percent control of Changchun Fangguan in December 2018. As a result, Ionix became an aggregator in the photoelectric display and smart energy fields in China, which has also laid a strong foundation for its prospective future development and technology innovation.

Last week, Ionix Technology announced its financial results for the three months ended March 31, 2019. Financial highlights include Total Revenues increasing by 146 percent from the three months ended March 31, 2018 to three months ended March 31, 2019. Gross Profit Margin was 22 percent during the three months ended March 31, 2019 versus 11 percent for the three months ended March 31, 2018.

Mr. Yubao Liu, Ionix Technology's Chief Executive Officer, said, "We are taking a persistent approach to build our business and continue to make investments in the fields of photoelectric display and smart energy. By integrating such operations we will gain competitive advantage and economic scale. The recent plan to accelerate investment in the OLED flexible screen market is a good example. We expect these efforts bring long-term growth for our shareholders."


Ionix Technology, Inc. (IINX), closed Monday's trading session at $1.70, down 0.26%, on 100 volume with 1 trade. The average volume for the last 3 months is 2,453 and the stock's 52-week low/high is $1.02/$2.75.


Relmada Therapeutics, Inc. (RLMD)

NetworkNewsWire, Real Investment Advice, Zacks, Super Stock Screener, Simply Wall St, Market Screener, Equities, Trading View, Marketbeat, Wallet Investor, Capital Cube, Street Insider, Stockhouse, Streetwise Reports, MarketWatch, InvestorsHub, and OTC Markets reported earlier on Relmada Therapeutics, Inc. (RLMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A clinical-stage company, Relmada Therapeutics, Inc. is developing REL-1017 (dextromethadone) in numerous indications. RELM-1017 is in Phase 2 for treatment resistant depression and preclinical testing for additional indications. Fundamentally, Relmada Therapeutics develops novel therapies for the treatment of central nervous system (CNS) diseases. Based in New York City, the Company lists on the OTC Markets Group's OTCQB.

The expectation is that Relmada's approach will lessen clinical development risks and costs. This is while potentially delivering valuable products to address areas of high unmet medical needs. Its lead program is dextromethadone (REL-1017). This is an N-methyl-D-aspartate (NMDA) receptor antagonist. NMDA receptor antagonists may have potential in the treatment of a range of psychiatric and neurological disorders associated with an assortment of cognitive, neurological and behavioral symptoms.

Relmada Therapeutics is targeting major advances in the treatment of CNS disorders. REL-1017 is currently in a Phase 2a trial for the treatment of Major Depressive Disorder (MDD). Moreover, there is significant potential in manifold additional indications. This includes Rett Syndrome.

Furthermore, Relmada has additional valuable pipeline assets for partnering. These include REL-1015 Levocap ER – a Phase 3-ready abuse deterrent formulation of a highly-potent opioid. Assets also include REL-1028 BuTab - an oral formulation of modified release buprenorphine for chronic pain. Additionally, assets include REL-1021 MepiGel – a novel topical version of local anesthetic mepivacaine for the treatment of painful peripheral neuropathies.

In April, Relmada Therapeutics announced that Ms. Gina DiGuglielmo joined Relmada as Vice President and Head Of Clinical Operations. Ms. DiGuglielmo previously served as Clinical Operations Advisor of the Company since June of 2017. In her new role, she will lead and oversee the clinical operations for Relmada's lead product candidate dextromethadone (REL-1017) and will contribute to the advancement of Relmada's portfolio in the clinical phases.

Moreover, last month, Relmada Therapeutics announced that results of its N-methyl-D-aspartate receptor (NMDAR) antagonist REL-1017 (dextromethadone) single ascending dose and multiple ascending dose studies were accepted for publication in the peer reviewed Journal of Clinical Psychopharmacology.

Dr. Ottavio Vitolo, SVP, head of R&D and Chief Medical Officer of Relmada Therapeutics, said, "Results from our Phase 1 studies indicate that REL1017 has the potential to offer a favorable safety and tolerability profile in the treatment of MDD as an oral NMDAR antagonist without the psychotomimetic and dissociative adverse events associated with ketamine and its recently approved stereoisomer esketamine. These studies also confirm that the pharmacological profile of REL1017 is different from that of its racemic form methadone. We look forward to completion of our Phase 2 trial in the first half of 2019 and the opportunity to learn more about the potential for REL-1017 to be a significant advance in the treatment of individuals with depression."

Relmada Therapeutics, Inc. (RLMD), closed Monday's trading session at $2.64, up 24.53%, on 66,362 volume with 120 trades. The average volume for the last 3 months is 23,685 and the stock's 52-week low/high is $0.80/$2.12.


Serica Energy plc (SQZZF)

Wallet Investor, Invest Tribune, Dividend Investor, Market Screener, Seeking Alpha, Stockhouse, MarketWatch, Trading View, Wallmine, Investors Hangout, Pink Investing, The Street, 4-Traders, Guru focus, and Barchart reported earlier on Serica Energy plc (SQZZF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Serica Energy plc is an independent upstream oil and gas company headquartered in London, United Kingdom (UK). The Company has operations focused on the UK North Sea where it has the full range of exploration, development, as well as production assets. Serica's primary emphasis is on building a portfolio of properties where it can use its technical, commercial and operating capabilities to add value to existing producing assets and to explore and develop new reserves. Established in 2004, Serica Energy lists on the OTC Markets.

Serica has proved the success of the above-mentioned model via its producing asset, Erskine, in which it is a partner with Chevron and Chrysaor. On November 30, 2018, the Company completed the acquisition of interests in the Bruce, Keith and Rhum fields where it also took over as field operator. These fields are a combination of late-life and mid-life, mainly gas producing assets where further investment can enhance recovery and extend field life.

The Bruce, Rhum and Keith fields in the UK Northern North Sea produce through the Serica operated Bruce facilities, consisting of three platforms with accommodation for up to 160 people. Serica Energy has drilled 23 wells since its inception in 2004, 17 as operator.

Serica has drilled wells across a broad spectrum of offshore geographies. This includes the UK, Ireland, Indonesia and Vietnam. As an operator, 14 of the 17 wells drilled by the Company encountered oil or gas, six of which were of commercial significance, leading to the discovery of Columbus in the UK North Sea and Kambuna in Indonesia.

Since its direct involvement in the Erskine operations, Serica Energy has contributed to a major improvement in the asset's production levels. Serica is the development operator for Columbus. It also developed the Kambuna field before selling its operated interest on favorable terms to the Company in 2008.

Serica Energy plc (SQZZF), closed Monday's trading session at $1.25, up 0.81%, on 16,640 volume with 16 trades. The average volume for the last 3 months is 270 and the stock's 52-week low/high is $0.025/$1.83.


Elio Motors, Inc. (ELIO)

Green Car Reports, The Verge, Stock Twits, Start Engine, Zacks, Nasdaq, Marketbeat, Green Car Congress, Tmxmoney, Stockhouse, InvestorsHub, Seeking Alpha, Insider Financial, Barchart, Stockwatch, Business Wire, OTC Markets, 4-Traders, Wallet Investor, PR Newswire, and GuruFocus reported earlier on Elio Motors, Inc. (ELIO), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Elio Motors, Inc. is the developer of the ultra-high-mileage, low-cost, three-wheel Elio vehicle. Car enthusiast, Mr. Paul Elio, founded the Company. A development stage enterprise, Elio concentrates on developing the Elio three-wheeled vehicle for mass production in America. Elio Motors has its corporate headquarters in Phoenix, Arizona. The Company's shares trade on the OTC Markets Group's OTCQB.

Elio Motors' first manufacturing site will be in Shreveport, Louisiana. The Company is taking advantage of existing automotive technologies and partnerships with the world's foremost automotive engineering firms and component suppliers.

The three-wheel Elio is engineered to achieve a highway mileage rating of up to 84 mpg. This is while providing the comfort of amenities including power windows, power door locks, air conditioning and cruise control, accompanied by the safety of numerous air-bags and an aerodynamic, enclosed vehicle body.

In September of 2018, Elio Motors announced it entered into a Memorandum of Understanding (MOU) with a Fortune 500 original equipment manufacturer (OEM), to provide the engine foundation as part of a new powertrain for the Elio vehicle. In September, Elio projected that the new powertrain will result in $120 million in research and development (R&D) cost savings. Elio Motors is working with the engineering team at Roush to develop a new Elio prototype utilizing the OEM powertrain.

Roush will integrate the new powertrain into Elio Motors' prototype in order to commence preliminary testing procedures. The testing procedures will prepare the Elio for production that will take place at the Elio Motors manufacturing facility in Shreveport, Louisiana.

The new powertrain will push the Elio's performance specifications considerably beyond previous consumer expectations. The engine should offer close to a 100 percent increase in horsepower rating versus initial Elio prototype vehicles. The expectation is that the new powertrain, when combined with the Elio's low curb weight, will deliver excellent driver response and a highly improved acceleration time.

Elio Motors, Inc. (ELIO), closed Monday's trading session at $2.01, up 0.50%, on 1,000 volume with 2 trades. The average volume for the last 3 months is 2,943 and the stock's 52-week low/high is $2.00/$5.15.


Enthusiast Gaming Holdings, Inc. (EGHIF)

Street Signals, Stockwatch, The Street, OTC Markets, Wallet Investor, MicroSmallCap, GlobeNewswire, Stockhouse, InvestorsHub, Seeking Alpha, Market Screener, GuruFocus, and Trading View reported earlier on Enthusiast Gaming Holdings, Inc. (EGHIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Formed in 2014, Enthusiast Gaming Holdings, Inc. is the fastest-growing online community of video gamers. The Company has a platform of more than 80 owned and affiliated websites. It currently reaches greater than 75 million monthly visitors with its innovative and curated content and over 50 million YouTube visitors. Enthusiast Gaming Holdings lists on the OTC Markets Group's OTCQB. The Company is headquartered in Toronto, Ontario.

Enthusiast Gaming concentrates on building the largest network of authentic gaming enthusiasts, via events, original content, as well as advertising. The Company also owns and operates Canada's largest gaming expo, Enthusiast Gaming Live Expo, EGLX, ( with more than 55,000 people attending last year.

Enthusiast Gaming's innovative growth strategy adds to the website monetization potential, which powers its platforms and partners. At present, the Company is generating more than one billion ad requests per week via Enthusiast Gaming Media and affiliated partners.

Last week, Enthusiast Gaming announced that its esports community, Daily Esports (, reported record-breaking quarterly visitor growth since the acquisition in March of last year. The digital property saw a 4X pageview increase within the quarter. This represents an increase of 135 percent in visitor traffic over the prior quarter. It has added 288,000 unique monthly visitors to its overall readership since the acquisition.

Since the acquisition, Enthusiast Gaming and its Director of Content, Niero Gonzalez and Director of Special Projects, Jason Lepine have built out the Daily Esports team. This includes new Editor-in-Chief, Taha Zaidi, and 28 freelance writers. Daily Esports is one of the top online communities of esports content around breaking news, game patches, analysis, opinion, tournament coverage, and more.

Yesterday, Enthusiast Gaming announced that it has, via a wholly-owned subsidiary, signed a definitive agreement to purchase 20 percent of the issued and outstanding shares in Waveform Entertainment, Inc. for total consideration of $1,680,000. Waveform Entertainment is a foremost esports broadcast and production company. It specializes in the organization of premium esports tournaments internationally. Furthermore, Enthusiast Gaming secured an irrevocable option, at its sole discretion, to acquire a 100 percent interest in Waveform.

Enthusiast Gaming Holdings, Inc. (EGHIF), closed Monday's trading session at $1.30, up 4.94%, on 11,186 volume with 11 trades. The average volume for the last 3 months is 14,382 and the stock's 52-week low/high is $0.6117/$1.36.


Galaxy Next Generation, Inc. (GAXY)

Simply Wall St, Wallet Investor, Dividend Investor, GuruFocus, GlobeNewswire, Teletrader, Market Screener, Modest Money, Barchart, The Street, Investors Hangout, Corporate Information, Last10k, MarketWatch, and Street Insider reported on Galaxy Next Generation, Inc. (GAXY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Galaxy Next Generation, Inc. (GAXY) is a U.S. distributor of interactive learning technology hardware and software, which create totally collaborative instructional environments. The Company's products include its own private-label interactive touch screen panel and many other national and international branded peripheral and communication devices. Galaxy Next Generation has its corporate headquarters in Toccoa, Georgia. The Company's shares trade on the OTC Markets Group's OTCQB.

Galaxy Next Generation's distribution channel includes more than 22 resellers across the United States. These resellers mainly sell the Company's products within the commercial and educational market. Typically, the K-12 education market is the largest customer base for Galaxy Next Generation products. This market comprises close to 90 percent of the Company's sales.

The Company works together with educators to help them develop teaching and learning in their Connected Classrooms. This new approach takes advantage of digital content, learning data, and one-of-a-kind technologies to create an immersive and interactive experience.

Galaxy's products include interactive panels, collaboration devices, panel accessories, and integrated PCs. The Company's software includes Ximbus and Oktopus. In addition, Galaxy offers an assortment of on-site training opportunities. The Company also focuses on premier after sales services.

In March, Galaxy Next Generation announced a new product offering where it has started to use online training resources for its products and customers. Mr. Gary LeCroy, Galaxy Next Generation's Chief Executive Officer, said, "We now have reference cards available for the software and hardware, step by step instructions on using the software and hardware, and we are even offering onsite training at the customers school or place of business as part of their purchase."

Furthermore, in March, Galaxy Next Generation announced that Newton County, Georgia, School District, a prior purchaser of G2 panels, will continue to purchase the Company's G2 panel as a standard. Mr. LeCroy said, "We are excited to be the official company awarded Newton County School District's G2 panel contract. It is always edifying to have an existing customer see the continued value of our products."

Galaxy Next Generation, Inc. (GAXY), closed Monday's trading session at $1.98, up 10.00%, on 5,250 volume with 10 trades. The average volume for the last 3 months is 13,327 and the stock's 52-week low/high is $0.735/$75.95.


SOL Global Investments Corp. (SOLCF)

Midas Letter, Whale Wisdom, CannabisMarketCap, Financial Buzz, InvestorIntel, MarketWatch, InvestorsHub, YCharts, Marijuana Stock Review, Marketbeat, Investor Ideas, Barchart, Pot Stock News, Market Screener, Business Wire, Investorx, and Stockwatch reported earlier on SOL Global Investments Corp. (SOLCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

SOL Global Investments Corp. is a global investment company listed on the OTC Markets' OTCQB. The Company centers on, but is not limited to, cannabis and cannabis related companies in legal U.S. States, the hemp and CBD (cannabidiol) marketplaces, and the developing European cannabis and hemp marketplaces. SOL Global Investments has its corporate headquarters in Toronto, Ontario. It also has offices in Fort Lauderdale, Florida, and London, England.

The Company has strategic investments and partnerships across cultivation, distribution and retail. These complement its research and development (R&D) program with the University of Miami. SOL Global is positioning the Company as a future frontrunner in the United States' medical cannabis industry.

SOL's investments include ECH Ltd.; Verano Holdings LLC; OG DNA Genetics, Inc.; Greenlight Pharmaceuticals Limited; University of Miami; and PRØHBTD Media, Inc. ECH is a group of companies at the vanguard of the European medical cannabis industry. Verano Holdings is a private, vertically integrated, licensed operator of cannabis cultivation, manufacturing and retail facilities across six key U.S. States and Puerto Rico.

OG DNA Genetics is one of the foremost companies in the Cannabis Industry. Greenlight Pharmaceuticals Limited (GreenLight Medicines) is a biopharmaceutical company focused on researching, developing and licensing molecules from proprietary cannabinoid formulations to target a spectrum of disease areas.

Last week, SOL Global Investments announced its intention to spin off its wholly-owned subsidiary, Scythian Biosciences, Inc. (SBI), into an independent, publicly-traded company. Upon closing of the Spin-off, expected to take place on or before September 30, 2019, SOL Global Investments' shareholders will own shares of both companies. With this Spin-off, SBI will be renamed "Impact Biosciences Corp." It will continue to pursue a drug development in the U.S. for the treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination drug candidate that is undergoing development under contract with the University of Miami.

Today, SOL Global Investments announced the completion of its acquisition of CannCure Investments, Inc. CannCure is a privately-held Ontario corporation that indirectly holds 100 percent of 3 Boys Farms, LLC, a Florida limited liability company with a Florida state license to cultivate, process and dispense medical marijuana.

3 Boys Farms' operations comprise 40,000 square feet of fully-operational greenhouses situated on an eight-acre parcel of land. The existing facilities include a two-acre outdoor mitigation space, which is run 100 percent with harvested rainwater, solar pumps and repurposed high-volume chilled air from the cultivation greenhouses. This results in a zero-carbon footprint. 3 Boys Farms' innovations include alternative energy use, greenhouse cooling designs, and rainwater harvesting. Its innovations were recognized and honored by the Governor's Environmental Leadership Award. Also, 3 Boys Farms has started extraction and processing operations at its new GMP-certified farm and laboratory facility in Indiantown, Florida.

SOL Global Investments Corp. (SOLCF), closed Monday's trading session at $1.83, up 18.75%, on 16,221 volume with 29 trades. The average volume for the last 3 months is 85,861 and the stock's 52-week low/high is $0.768/$4.98.


Surna, Inc. (SRNA)

Hot Stock Profits, Ascending Stocks, OTC Stock Review, Promotion Stock Secrets, Wall Street Mover, TopPennyStockMovers, PricelessPennyStocks, MarketWatch, Stockhouse, InvestorsHub, Market Wire Stocks, Best Medical Marijuana Stocks, Value Penny Stocks, Cannabis Financial Network News, SmallCapVoice, Marketbeat, CFN Media Group, PennyStockRumors, DSR News, Greenbackers, PHUB News, and Actual Gains reported earlier on Surna, Inc. (SRNA), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Surna, Inc. develops, acquires, produces, and sells equipment for the legal marijuana industry. The Company develops innovative technologies and products to monitor, control, and address the energy and resource intensive nature of indoor cannabis cultivation. Its corporate mission is to acquire intellectual property (IP) and scalable operating companies in the nascent, legal marijuana industry with a concentration on disruptive technology, equipment, and related support services. A technology business and OTCQB-listed, Surna is headquartered in Boulder, Colorado.

The Company's objective is to dominate the infrastructure, growing, and support side of the worldwide cannabis industry. The foundation of Surna's present revenue stream is on its chief product offerings - supplying industrial technology and products to commercial indoor cannabis grow facilities. The Company engineers, manufactures, and distributes state-of-the art equipment and systems for Controlled Environment Agriculture (CEA).

Currently, Surna's specialty is commercial indoor cannabis cultivation. Its business model excludes the production or sale of marijuana. By way of its wholly-owned subsidiary, Hydro Innovations, the Company provides a comprehensive line of commercial and small business indoor agriculture equipment.

It has its signature water-cooled climate control platform. Surna's plan is to integrate this and other proprietary technology into a new, commercial-grade power-generating and environmental control system product. This system is undergoing design to provide a near zero waste energy alternative for the cannabis industry.

Surna has its new business model and strategy. The Company will work to decrease its reliance on new build facility projects that generate inconsistent revenue and cash flow. It will also establish revenue from "lifecycle" operational and facility management offerings and operate with a more disciplined expense, cash and working capital management. Furthermore, Surna will work to become financially self-sustaining through attempting to attain cash flow breakeven and operating profit and will raise capital for strategic initiatives when the return on investment (ROI) is quantifiable and justified.

Late last year, Surna decided tocus its next major product initiative in the sensors, controls and automation (SCA) market. It has entered this business to satisfy its customers' needs that the Company did not earlier address and that historically was provided by third-party controls contractors. Surna will be one of the few mechanical systems providers in the market to offer a branded, proprietary HVAC equipment package and a branded SCA product line. 

Surna, Inc. (SRNA), closed Monday's trading session at $0.04928, up 18.75%, on 978,864 volume with 84 trades. The average volume for the last 3 months is 607,041 and the stock's 52-week low/high is $0.04/$0.215.


NexOptic Technology Corp. (NXOPF)

Penny Stock Hub, Wallet Investor, InvestorsHub, Market Screener, Financial Content, Barchart, Capital Cube, Real Investment Advice, Insider Financial, 4-Traders, Morningstar, Penny Stock Tweets, Equedia, Stockhouse, and MarketWatch reported beforehand on NexOptic Technology Corp. (NXOPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NexOptic Technology Corp. is a creative optical development company listed on the OTCQX. At present, the Company is concentrating on the development of its initial consumer product for the emergent outdoor recreation market, and also a demonstration prototype for the mobile device space. NexOptic Technology is headquartered in Vancouver, British Columbia.

Utilizing Blade Optics™, the Company's developing family of unique optical technologies, NexOptic Technology aims to increase aperture sizes within given depth constraints of different imaging applications. Increasing the aperture enables a lens system to have an improved diffraction limit, providing the potential for considerably increased resolution.

Blade Optics™ refers to the Company's lens designs, algorithms and mechanics. These vary from patented to patent-pending and include all of NexOptic's intellectual property (IP) and expertise. NexOptic has completed the design basis intended for its first commercial products in the sport optics marketplace. Two product designs were completed - a pocketable consumer version and a premium 'prosumer' model.

The Company has developed and continues to refine innovative artificial intelligence networks (AI) for photography. NexOptic Technology's engineered AI substantially lessens image noise and motion blur common in poor lighting imaging environments through leveraging deep convolutional neural networks.

Further to enhancing image quality, the technology could be used to improve long-range image stabilization and image capture in extreme lighting conditions. The Company's belief is that the technology will have major commercial applications in a number of industry verticals. It also believes it has the potential to be incorporated into the Company's current sport optics and smartphone lens offerings.

Last month, NexOptic Technology announced that DoubleTake™, its "Binoculars Reimagined", has been nominated as a 2019 Edison Award™ Finalist for Advanced Image Capture in the Consumer Goods category. DoubleTake is the Company's pioneering reimagining of binoculars powered by a dual Blade Optics™ lens system.

DoubleTake features an equivalent focal length of more than 500mm. Therefore, users can capture remarkable images and lifelike 4K video. DoubleTake features a quad-core Ambarella H2 processor, enabling state-of-the-art digital features including image stabilization and real-time, high resolution panning, all viewable by way of a 5-inch high-definition touch screen LCD display.

Last week, NexOptic Technology announced that Mr. Richard J. Geruson joined the Company's Board of Directors, effective immediately. Mr. Geruson's experience encompasses Chief Executive Officer roles at Lexmark International, Phoenix Technologies and VoiceSignal Technologies, and Senior Vice President and Executive positions at Nokia, IBM, Toshiba, and McKinsey & Co. He has served on manifold public and private boards across three continents. Moreover, Mr. Geruson holds graduate degrees from Oxford University, including a D.Phil. in economics.

NexOptic Technology Corp. (NXOPF), closed Monday's trading session at $0.44, up 17.68%, on 26,738 volume with 14 trades. The average volume for the last 3 months is 45,900 and the stock's 52-week low/high is $0.27/$0.85.


The QualityStocks Company Corner

Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGRMF).

Anticipating the legalization of adult-use cannabis edibles, and ready to demonstrate a leadership position in the edibles market, Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQX:OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce a $15 million investment commitment in a high-speed, high-capacity, fully-automated production line with ability to produce an estimated 4 million kilograms of exceptional chocolate cannabis edibles per year. Also today, the company was highlighted in the Venture Breakfast Bits by 24/7 Market News.

Organigram Holdings Inc. (TSX.V: OGI) (OTC: OGRMF) is the parent company of Organigram Inc., an original and leading Canadian licensed producer ("LP") of premium, quality cannabis and extract-based products. Founded in 2013 and headquartered in Moncton, New Brunswick, Canada, Organigram is focused on producing the highest-quality indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company's global footprint.?

Organigram delivers industry-leading yields and maximizes cannabis production at the lowest cultivation cost among other Canadian licensed producers. Organigram's high-tech facilities utilize an efficient, state-of-the-art mechanical room that includes both ethanol and CO2 extraction methods.

The company first began as a medical cannabis provider producing 5,000 kg/year (11,000 lbs) of 100 percent organic cannabis grown in pre-fabricated grow pods. Within two years, Organigram increased production to 36,000 kg/year (70,000 lbs) by utilizing an inventive, indoor 3-tier growing system. The company's pharmaceutical grade, state-of-the-art facility currently houses over 45,000 flowering plants growing at any one time.

Organigram's head office, production facility and research & development program are located on the company's 14-acre campus that houses several buildings and a 40-megawatt substation. Leading the way with a proprietary software system that acts as the nervous system of the entire organization, Organigram's team employs a data-driven decision-making process that ensures efficiency and top yields. Numerous design and automation improvements include an ergonomically friendly grow room design, automatic potting machines and automated packaging lines, and larger propagation rooms with advanced environmental systems.

Organigram's fully funded Phase 4 expansion is underway which, when complete by fall of 2019, will bring production capacity of high-quality premium cannabis to 113,000 kg/year (249,000 lbs). The Company has also invested in Hyasynth, a Montreal-based biotechnology company and leader in the field of cannabinoid science and biosynthesis. Hyasynth has developed a disruptive technology using patented enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation.

Organigram expects to double its workforce within the year to accommodate increasing growth as the facility expands to 480,000 square feet of production space at full buildout. In September 2017, Organigram signed the first ever recreational cannabis supply agreement in Canada with the Province of New Brunswick. Since then, Organigram has signed similar supply agreements with nine out of 10 provinces, has already exported product out of Canada, and is currently working with German medical cannabis provider, Alpha-cannabis, and Serbia-based Eviana Health Corp. (CSE: EHC), a hemp farm and processing facility.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado, with 16 retail locations, for development of commercial scale extraction and product processing, along with derivative product development (edibles, vaporizable products and beverage product mixes). Organigram's partnership with Canada's Smartest Kitchen, a leader in food product development, will expand and develop the Company's edibles R&D program and creation of premium chocolate products. Organigram has also signed a multi-year extraction contract with Valens GroWorks Corp. for Valens to produce extract concentrate for oils and derivative products.

Organigram is well-positioned in the cannabis space with several adult-use recreational product lines. These include:

  • Trailblazer offers a consistent value with a pre-roll, milled format
  • Trailer Park Buds provides niche equity for mainstream users that seek pre-rolls
  • Ankr Organics offers premium, organic pre-roll and oils
  • Edison Cannabis Co. delivers robust, high THC in a whole flower, pre-roll and oil produced from premium sorted flowers
  • Edison Cannabis Co. Reserve offers an ultra-premium, large whole flower that is craft cured and hand trimmed

Experienced Executive Team

  • CEO Gregory Engel has more than 30 years of experience in the pharmaceutical industry with over three years of experience as a CEO for a cannabis company.
  • Jeff Purcell, senior vice president of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods.
  • Tim Emberg, senior vice president of sales and commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and consumer packed good industry.
  • Guillermo Delmonte, president of international operations, brings experience in leading a global cannabis company and worked for 2.5 years as CEO of ICC Labs Inc. in Uruguay.
  • Larry Rogers, vice president of international operations, has held roles for Organigram since 2014 including being a member of the board of directors, chief operating officer and vice president/business development.
  • Paolo DeLuca, chief financial officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities.
  • Ray Gracewood, chief commercial officer, has 15 years of experience in the marketing space and is a previous senior director of sales and marketing for Moosehead Breweries Ltd.
  • Michael Tripp, chief legal officer, worked for private practices at respected business law firms in Moncton and Toronto where he acted on over $3 billion in transactions.

Organigram Holdings Inc. (OTCQX: OGRMF), closed the day's trading session at $8.35, up 4.64%, on 2,048,866 volume with 2,874 trades. The average volume for the last 3 months is 914,719 and the stock's 52-week low/high is $2.97/$8.14.

Recent News


Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) develops and designs brands that focus on plant-based health and wellness products. Wildflower has an innovative and holistic business model that incorporates research and development (R&D), manufacturing, distribution, marketing and retail. Also today, NetworkNewsWire released a report on the company detailing how WLDFF was featured on MindBodyGreen in '14 CBD-Infused Beauty & Self-Care Products That Should Already Be In Your Home'.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.538775, up 7.45%, on 14,710 volume with 13 trades. The average volume for the last 3 months is 23,115 and the stock's 52-week low/high is $0.009/$1.129.

Recent News


Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Recent short-term energy outlook reports issued by the U.S. Energy Information Agency ("EIA") illustrate the volatility of the world's crude oil supply as geopolitical forces affect production and predicted demand outpaces supply. Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) and its environmentally-friendly oil extraction technology has the potential to revolutionize America's energy independence by releasing heavy oil resources hidden in oil sands and oil shale deposits without harming the environment.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PHVAF), closed the day's trading session at $0.40, up 5.26%, on 122,944 volume with 47 trades. The average volume for the last 3 months is 203,490 and the stock's 52-week low/high is $0.242/$1.43.

Recent News


Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions Inc. (OTCQB: SGSI) in Q1 2019 reported its first quarter with positive income from operations. For the three months ended March 31, 2019, SGSI reported revenues of $11,335,732, as compared to sales of $4,327,764 the first quarter of 2018. In 2019, the company showed its first quarterly income from continuing operations of $14,699, as compared to a loss from operations of $743,491 during the same period in 2018 (

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.


CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.14, up 3.70%, on 146,711 volume with 15 trades. The average volume for the last 3 months is 105,726 and the stock's 52-week low/high is $0.071/$2.59.

Recent News


TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE:TCAN: XETR: TH8) ("TransCanna" or the "Company") is pleased to announce the execution of a non-binding Letter Of Intent dated May 17, 2019 (the "LOI") with Lyfted Farms, Inc. ("Lyfted"), of Modesto, California, to acquire the business and assets of Lyfted (the "Proposed Acquisition"). Lyfted Farms is a state licensed producer of high quality indoor grown cannabis.  The three permanent state licenses that Lyfted owns are for cultivation (nursery), cultivation (grow), and distribution.  

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $6.78, off by 1.74%, on 42,392 volume with 67 trades. The average volume for the last 3 months is 166,133 and the stock's 52-week low/high is $0.769/$7.789.

Recent News


Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a branded, cannabis-infused products manufacturer, recently announced exciting developments in its quest to dominate the edibles market. The company continues its innovation of low-dose, delicious cannabis edibles with a new line of mints.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $3.62, up 4.93%, on 54,046 volume with 96 trades. The average volume for the last 3 months is 74,101 and the stock's 52-week low/high is $2.81/$6.01.

Recent News


Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood, Inc. (OTCQB: NGTF), the innovative ice cream company solving America's $50 billion-dollar nighttime snacking problem, was prominently featured in a Wall Street Journal article about the birth of the potentially massive nighttime specific food and beverage category. Also today, the company was highlighted in the Venture Breakfast Bits, by 24/7 Market News.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at through the Company’s partnership with

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category ( Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed the day's trading session at $0.595, off by 0.83%, on 100,884 volume with 67 trades. The average volume for the last 3 months is 354,261 and the stock's 52-week low/high is $0.16/$0.92.

Recent News


VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) was featured today in the 420 with CNW by CannabisNewsWire. As the deadline set by Gov. Murphy to have the bill to legalize recreational cannabis passed approaches, the Department of Health has released the proposed rule changes which will see the medical cannabis program expanded. The program was due to be expanded at the same time as the legalization of recreational weed, but that seems to be failing as lawmakers fail to convince 2-5 other senators to support full legalization.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.498, off by 0.40%, on 78,904 volume with 64 trades. The average volume for the last 3 months is 280,491 and the stock's 52-week low/high is $0.413/$1.53.

Recent News


VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTC: VPRB), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates and extracts (CBD), as well as electronic cigarettes containing nicotine, announces its first quarter 2019 financial results, posting increased revenues and a narrowed net loss as compared to 2018. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. As the deadline set by Gov. Murphy to have the bill to legalize recreational cannabis passed approaches, the Department of Health has released the proposed rule changes which will see the medical cannabis program expanded. The program was due to be expanded at the same time as the legalization of recreational weed, but that seems to be failing as lawmakers fail to convince 2-5 other senators to support full legalization.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit? more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed the day's trading session at $0.0586, off by 1.18%, on 11,000 volume with 3 trades. The average volume for the last 3 months is 76,291 and the stock's 52-week low/high is $0.026/$0.139.

Recent News


Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (OTCMKTS: DVLP) ("DVLP" or the "Company"), an emerging leader in the Cannabis, Hemp, and CBD marketplace, is excited to announce Lease of a new 25,000 square-foot production facility located in Denver, CO. Also today, Golden Developing Solutions announced its finalization of a lease for a new 25,000-square-foot production facility located in Denver, Colorado.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website ( and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially. has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.0163, off by 28.51%, on 14,293,082 volume with 309 trades. The average volume for the last 3 months is 4,253,421 and the stock's 52-week low/high is $0.0122/$0.14.

Recent News


Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s "Choom Gang," a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with "choom," the local's term for marijuana. Choom's trademark slogans pivot off another unconventional phrase ("Say Hello to…"), bringing a heady dose of good times and good friends together as the company invites investors to "Say Hello to Choom™" as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company's first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom's initial license applications to ensure the company's readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company's character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1's revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic "Aloha" vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company's growth strategy. Get ready to "Say Hello" to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.40, up 2.56%, on 147,672 volume with 68 trades. The average volume for the last 3 months is 612,645 and the stock's 52-week low/high is $0.285/$1.129.

Recent News


Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH).

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company's commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ ("UMI") solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company's UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum's wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company's UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI's technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum's primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum's management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum's management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

Consorteum Holdings, Inc. (CSRH), closed the day's trading session at $0.0006, even for the day, on 95,000 volume. The average volume for the last 3 months is 515,991 and the stock's 52-week low/high is $0.0005/$0.0045.

Recent News


Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated ( “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.13, up 14.04%, on 2,500 volume with 3 trades. The average volume for the last 3 months is 29,578 and the stock's 52-week low/high is $0.07/$0.377.

Recent News


Cool Events Inc. (RNWR)

The QualityStocks Daily Newsletter would like to spotlight Cool Events Inc. (RNWR).

Cool Events Inc. (RNWR) offers an array of unique, experiential running and obstacle events that attract thousands of participants sharing a passion for running and helping others. The company produced over 120 events in 2018 under the banner of five successful brands and has already lined up venues for 2019.

Cool Events offers the following trademarked events throughout the nation, with each dedicated to raising funds for important charities: Blacklight Run, the largest glow powder run in the world; Bubble Run, the largest daytime 5K run in the country; Foam Glow, The largest nighttime glow run in the country and the world’s only glowing foam run; Blacklight Slide, the first and only close to five story high Glow-N-Dark water slide with neon glowing water; and Terrain Race, the nation’s fastest growing and industry leading obstacle course race for all ages and athletic abilities.

Cool Events dedicates each of its trademarked runs and events to childhood cancer awareness, making sure this critically important issue is spread throughout the nation one runner, one race at a time. Since its first event in August 2013, the company has donated more than $1 million to Phoenix Children’s Hospital/Children’s Miracle Network and hundreds of thousands more to other charity partners such as Ronald McDonald House Charities of New Mexico, Make-a-Wish Foundation, Adoption Awareness, Special Olympics Massachusetts, St. Jude Children’s Research Hospital, Kendra’s Kisses, Boys and Girls Club and many more over the years.

Cool Events brings a seasoned management team with 35 years of combined experience in operating experiential events including obstacle course races, running races, experiential family events and other competitive events. The Cool Events team also offers consulting, marketing and development for outside events. The company’s in-house marketing agency can handle all brand awareness for event strategy, bringing an event’s vision and goals to life.

Cool Events Inc. (RNWR), closed the day's trading session at $0.0651, even for the day, on 27,490 volume. The average volume for the last 3 months is 8,758 and the stock's 52-week low/high is $0.002/$0.231.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.